Take Solutions [TAKE] vs OneSource Specialty [ONESOURCE] Detailed Stock Comparison

Take Solutions Ltd.

NSE
Loading...

OneSource Specialty Pharma Inc.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Take Solutions Ltd. wins in 5 metrics, OneSource Specialty Pharma Inc. wins in 10 metrics, with 1 ties. OneSource Specialty Pharma Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Take Solutions Ltd. OneSource Specialty Pharma Inc. Better
P/E Ratio (TTM) 281.47 936.63 Take Solutions Ltd.
Price-to-Book Ratio 28.05 3.11 OneSource Specialty Pharma Inc.
Debt-to-Equity Ratio 0.00 21.93 Tie
PEG Ratio -1.72 42.24 OneSource Specialty Pharma Inc.
EV/EBITDA -117.76 40.79 OneSource Specialty Pharma Inc.
Profit Margin (TTM) 0.00% 1.42% OneSource Specialty Pharma Inc.
Operating Margin (TTM) -24.04% -18.02% OneSource Specialty Pharma Inc.
Return on Equity 182.53% -0.31% Take Solutions Ltd.
Return on Assets (TTM) 102.71% -0.24% Take Solutions Ltd.
Free Cash Flow (TTM) $-163.66M $-1.96B Take Solutions Ltd.
1-Year Return 230.77% -20.38% Take Solutions Ltd.
Price-to-Sales Ratio (TTM) -101.88 13.01 OneSource Specialty Pharma Inc.
Enterprise Value $7.78B $195.90B OneSource Specialty Pharma Inc.
EV/Revenue Ratio -110.37 13.80 OneSource Specialty Pharma Inc.
Gross Profit Margin (TTM) N/A 67.50% N/A
Revenue per Share (TTM) $-1 $124 OneSource Specialty Pharma Inc.
Earnings per Share (Diluted) $-0.10 $1.72 OneSource Specialty Pharma Inc.
Beta (Stock Volatility) 0.57 N/A N/A

Take Solutions Ltd. vs OneSource Specialty Pharma Inc. Stock Performance Analysis

Loading Price Chart...

TAKE
ONESOURCE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Take Solutions Ltd.-0.47%0.24%15.35%-27.05%-15.27%-26.80%
OneSource Specialty Pharma Inc.0.68%-6.58%-11.52%8.72%0.44%-9.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Take Solutions Ltd.230.77%72.00%-55.11%-82.17%-25.92%-67.07%
OneSource Specialty Pharma Inc.-20.38%-5.70%-5.70%-5.70%-5.70%-5.70%

Performance & Financial Health Analysis: Take Solutions Ltd. vs OneSource Specialty Pharma Inc.

MetricTAKEONESOURCE
Market Information
Market Cap i₹7.19B₹202.76B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,346,1411,038,625
90 Day Avg. Volume i784,427610,058
Last Close₹29.53₹1,623.40
52 Week Range₹8.33 - ₹50.14₹1,057.00 - ₹2,248.00
% from 52W High-41.10%-27.78%
All-Time High₹308.25 (Jun 11, 2018)₹2,248.00 (Jun 18, 2025)
% from All-Time High-90.42%-27.78%
Growth Metrics
Quarterly Revenue Growth-0.83%-0.26%
Quarterly Earnings Growth-0.98%N/A
Financial Health
Profit Margin (TTM) i0.00%0.01%
Operating Margin (TTM) i-0.24%-0.18%
Return on Equity (TTM) i1.83%0.00%
Debt to Equity (MRQ) i0.0021.93
Cash & Liquidity
Book Value per Share (MRQ)₹1.75₹518.08
Cash per Share (MRQ)₹0.01₹14.56
Operating Cash Flow (TTM) i₹222.09M₹-2,152,760,000
Levered Free Cash Flow (TTM) i₹374.67M₹-179,710,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Take Solutions Ltd. vs OneSource Specialty Pharma Inc.

MetricTAKE (Apr 22, 2026)ONESOURCE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i281.47936.63
Forward P/E i2.7342.24
PEG Ratio i-1.7242.24
Price to Sales (TTM) i-101.8813.01
Price to Book (MRQ) i28.053.11
Market Capitalization
Market Capitalization i₹7.19B₹202.76B
Enterprise Value i₹7.78B₹195.90B
Enterprise Value Metrics
Enterprise to Revenue i-110.3713.80
Enterprise to EBITDA i-117.7640.79
Risk & Other Metrics
Beta i0.57N/A
Book Value per Share (MRQ) i₹1.75₹518.08

Financial Statements Comparison: Take Solutions Ltd. vs OneSource Specialty Pharma Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTAKE (2025)ONESOURCE (2025)
Revenue/Sales i014.45B
Cost of Goods Sold i04.35B
COGS % of Revenue i-30.1%
Gross Profit i010.10B
Gross Margin i-69.9%
Research & Development iN/A20.49M
Operating Income (EBIT) i-72.81M1.90B
Operating Margin i-13.2%
EBITDA i29.83M4.71B
EBITDA Margin i-32.6%
Pre-Tax Income i7.38M-670.66M
Pre-Tax Income % of Revenue i--4.6%
Income Tax i0-497.85M
Income Tax % of Revenue i--3.4%
Net Income (Profit) i374.67M-179.71M
Profit Margin i--1.2%

Balance Sheet & Liquidity Metrics

MetricTAKE (2025)ONESOURCE (2025)
Cash & Equivalents i33.67M1.56B
Total Current Assets i235.52M10.86B
Total Current Assets % of Revenue i-75.2%
Total Current Liabilities i159.54M11.14B
Total Current Liabilities % of Revenue i-77.1%
Long-Term Debt i03.83B
Long-Term Debt % of Revenue i-26.5%
Total Shareholders Equity i205.27M58.81B
Retained Earnings i-6.67B-18.43B
Retained Earnings % of Revenue i--127.6%
Property, Plant & Equipment i08.97B

Cash Flow Statement Comparison

MetricTAKE (2025)ONESOURCE (2025)
Operating Cash Flow i222.09M-2.15B
Operating Cash Flow % of Revenue i--14.9%
Capital Expenditures i0N/A
Free Cash Flow i-163.66M-1.96B
FCF Margin i--13.6%
Debt Repayment iN/A-6.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTAKEONESOURCE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i146.22M114.64M
Float Shares i78.49M70.43M
% Held by Insiders i12.12%38.63%
% Held by Institutions i0.00%26.67%
% Held by Public i87.88%34.70%

Dividend Analysis & Yield Comparison: Take Solutions Ltd. vs OneSource Specialty Pharma Inc.

MetricTAKEONESOURCE
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A